(Q74199840)
Statements
Prospective phase II trial of alternating intravesical Bacillus Calmette-Guérin (BCG) and interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: preliminary results (English)
M A Raja
A El Sayed
A Ezzat
E Ibrahim
S Kattan
A Kardar
A Peracha
E Lindstedt